FDA approves new sunscreen ingredient used for years in Europe and Asia

FDA Approves New Sunscreen Ingredient Used for Years in Europe and Asia

FDA approves new sunscreen ingredient used – After two decades of stagnation, the U.S. Food and Drug Administration (FDA) has made a landmark decision by approving a novel sunscreen ingredient—bemotrizinol, commonly referred to as BEMT—that has been safely utilized in Europe and Asia for over two decades. This approval marks a pivotal moment for the sunscreen industry, as experts emphasize that BEMT offers a more secure alternative to many of the chemical compounds currently dominating the American market. The move is anticipated to invigorate competition and bolster consumer trust in sun protection products, according to Secretary of Health and Human Services Robert F. Kennedy, who hailed the change in a statement.

A Safer Alternative for Sun Protection

The Environmental Working Group (EWG), a nonprofit organization focused on health and environmental advocacy, has long highlighted the limited options available in the U.S. for sunscreens that are both safe and effective. Their annual report underscores that the majority of products on store shelves fall short in providing comprehensive UVA protection, a critical factor in preventing long-term skin damage. Bemotrizinol, a chemical filter, stands out for its ability to deliver robust UVA shielding while minimizing absorption into the skin, a feature that distinguishes it from conventional chemical ingredients. This characteristic, combined with its strong safety profile, positions it as a game-changer in the field of sun care.

“Bemotrizinol changes the calculus of sun care. It is highly photostable—meaning it won’t break down when hot summer sun hits your skin—unlike avobenzone, currently the only non-mineral filter in the U.S. that provides meaningful UVA coverage,” stated Alexa Friedman, a senior scientist at the EWG. “Better yet, unlike older non-mineral filters, it can be combined with zinc oxide to provide strong broad-spectrum protection with less white cast.”

The UVA Protection Gap in U.S. Sunscreens

While modern sunscreens in the U.S. excel at blocking UVB radiation, which causes immediate visible sunburns, they often underperform against UVA rays. These rays penetrate deeper into the skin, contributing to premature aging, immune suppression, and skin cancer risk, as noted by the American Cancer Society. Peer-reviewed studies conducted by the EWG reveal that U.S. sunscreens, on average, offer only 24% of the UVA protection claimed by their SPF labels. This discrepancy has sparked concerns about the adequacy of current formulations, particularly in safeguarding against the long-term effects of sun exposure.

Mineral-based sunscreens, which rely on ingredients like zinc oxide and titanium dioxide, have been gaining traction for their physical approach to UV protection. Unlike chemical sunscreens, these products sit on the surface of the skin, deflecting and blocking sunlight without entering the dermis. This method reduces the likelihood of skin irritation or toxicity, making them a preferred choice for many consumers. However, the widespread use of chemical filters has raised questions about their safety, especially after the FDA’s 2019 findings revealed that six commonly used ingredients could reach unsafe levels in the bloodstream after just one day of application.

The FDA’s 2019 Findings and Industry Response

The 2019 FDA review of sunscreen chemicals brought attention to the potential systemic effects of certain ingredients. Research indicated that homosalate and oxybenzone, two of the most prevalent filters, remained detectable in the bloodstream for more than two weeks, exceeding safety thresholds. These findings prompted calls for further investigation into the long-term impacts of chemical sunscreens, though no updated regulations have been enacted to date. As a result, the approval of BEMT represents a critical step forward, offering a chemical option with a stronger safety foundation and improved UVA protection.

While the FDA has mandated that manufacturers conduct research on a dozen chemicals before they can be labeled as GRASE (generally regarded as safe and effective), the absence of conclusive data has left many consumers wary. The EWG’s 2026 report, which recommends 550 sunscreen products, highlights that 497 of these are primarily mineral-based. This shift toward mineral formulations reflects growing demand for products that prioritize safety without compromising efficacy. Yet, the introduction of BEMT could further diversify the market, providing a balance between the benefits of chemical and mineral ingredients.

Progress and Remaining Challenges

David Andrews, the chief science officer at the EWG, celebrated the FDA’s decision as a long-awaited victory for American consumers. “For decades, Americans have used outdated sunscreen technology while the rest of the world moved forward. The approval of bemotrizinol will help change that,” he remarked. Andrews emphasized that the new ingredient could close the UVA protection gap, a significant issue in U.S. sunscreens that has been persistent for years.

Despite this progress, the Personal Care Products Council (PCPC), which advocates for sunscreen manufacturers, remains cautious. In a statement, PCPC spokesperson Tesia Williams acknowledged the FDA’s action as “a significant advancement for the personal care products industry and consumers” but urged continued efforts to modernize the approval process. “While we commend the FDA for this progress, more work is needed to establish a streamlined and efficient framework for evaluating new sunscreen active ingredients,” she said. This sentiment underscores the ongoing debate between regulatory rigor and innovation in the sun care sector.

The approval of BEMT also aligns with broader trends in consumer preferences. With increasing awareness of the risks associated with chemical sunscreens, many users are seeking alternatives that are less likely to cause adverse reactions. Bemotrizinol’s unique properties—such as its photostability and compatibility with mineral ingredients—make it an attractive option for manufacturers aiming to meet these demands. As a result, the ingredient’s U.S. debut is expected to spark a new wave of sunscreen formulations, potentially redefining the landscape of sun protection for years to come.

Experts believe that the integration of BEMT into the American market could address the dual challenges of safety and efficacy, particularly in combating UVA radiation. Its robust safety data, combined with the ability to offer broad-spectrum protection without the drawbacks of traditional chemical filters, positions it as a promising solution. While the journey to approving new sunscreen ingredients has been slow, the FDA’s recent decision signals a renewed commitment to innovation and consumer well-being. This development not only enhances the availability of safer products but also sets a precedent for future advancements in sun care technology.